Vulnerability Description
Multiple cross-site scripting (XSS) vulnerabilities in Claroline 1.5.3 through 1.6 Release Candidate 1, and possibly Dokeos, allow remote attackers to inject arbitrary web script or HTML via (1) exercise_result.php, (2) exercice_submit.php, (3) agenda.php, (4) learningPathList.php, (5) learningPathAdmin.php, (6) learningPath.php, (7) userLog.php, (8) tool parameter to toolaccess_details.php, (9) data parameter to user_access_details.php, or (10) coursePath parameter to myagenda.php.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Claroline | Claroline | 1.5.3 |
References
- http://marc.info/?l=bugtraq&m=111464607103407&w=2
- http://secunia.com/advisories/15161ExploitPatchVendor Advisory
- http://secunia.com/advisories/15725
- http://securitytracker.com/id?1013822ExploitPatchVendor Advisory
- http://www.claroline.net/news.php#85ExploitPatchVendor Advisory
- http://www.securityfocus.com/bid/13407ExploitPatchVendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/20295
- http://marc.info/?l=bugtraq&m=111464607103407&w=2
- http://secunia.com/advisories/15161ExploitPatchVendor Advisory
- http://secunia.com/advisories/15725
- http://securitytracker.com/id?1013822ExploitPatchVendor Advisory
- http://www.claroline.net/news.php#85ExploitPatchVendor Advisory
- http://www.securityfocus.com/bid/13407ExploitPatchVendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/20295
FAQ
What is CVE-2005-1374?
CVE-2005-1374 is a vulnerability with a CVSS score of 6.8 (MEDIUM). Multiple cross-site scripting (XSS) vulnerabilities in Claroline 1.5.3 through 1.6 Release Candidate 1, and possibly Dokeos, allow remote attackers to inject arbitrary web script or HTML via (1) exerc...
How severe is CVE-2005-1374?
CVE-2005-1374 has been rated MEDIUM with a CVSS base score of 6.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2005-1374?
Check the references section above for vendor advisories and patch information. Affected products include: Claroline Claroline.